Shree Hari Chemicals: ₹40.24 Cr Warrant Issue in 2026

What the board approved on August 25, 2026

Shree Hari Chemicals Export Limited approved a preferential issue of convertible warrants worth ₹40.24 crore at its board meeting held on August 25, 2026. The proposal involves issuing 22,85,000 convertible warrants at ₹176.10 per warrant. The company stated the issuance is subject to shareholder approval, indicating that the fund-raising is not yet final until the required approvals are received. Each warrant is convertible into one equity share. The equity shares have a face value of ₹10 and are issued at a premium of ₹166.10 per share, taking the effective conversion price to ₹176.10.

The company’s disclosures also indicate that the warrants are being allotted to promoter entities. The preferential nature of the issue means the securities are not being offered to the broader public at this stage but to identified allottees. The update places the move within a formal corporate action framework where a board approval is followed by shareholder approval and subsequent allotment and conversion steps.

Issue structure: size, price, and instrument details

The board approved 22.85 lakh warrants (22,85,000) with an aggregate value of ₹40.24 crore. The price per warrant is ₹176.10. Each warrant is convertible into one equity share, linking the potential future equity dilution directly to the number of warrants issued. The company specified the equity share face value at ₹10 and premium at ₹166.10, consistent with the overall issue price.

Because warrants convert into equity, the final impact on the share capital will depend on the extent and timing of conversions, within the permitted window. The company has also indicated that conversion can take place in one or more tranches. This allows the allottees to convert part of the holding earlier and the remainder later, provided the overall timeline is met.

Who is receiving the warrants

The warrants are proposed to be allotted to four promoter entities: Shri Nihit Agarwal, Smt Priyamvada Agarwal, Smt Avanticka Agarwal, and Smt Smradhi Agarwal. The company’s key highlights also noted the post-conversion promoter holding percentages, indicating a range from 5.36% to 8.13% for the promoters after conversion.

While the excerpt references a table detailing proposed allotment and the post-conversion shareholding pattern, the complete row-wise allotment numbers were not provided in the text shared. What is explicitly stated is that allottees are promoters, and the company has indicated the expected post-conversion shareholding range for the promoter participants.

Payment schedule and conversion timeline

Shree Hari Chemicals Export outlined the payment terms for the warrants. Investors must pay 25% of the issue price at the time of subscription and allotment. The remaining 75% is payable on or before the exercise of the conversion right. This split payment structure is typical for warrant issues and directly affects the timing of cash inflows to the company.

The company also set a firm conversion timeline: the warrants must be converted within 18 months from the date of allotment, and conversion can occur in one or more tranches. If warrants are not converted within the tenure, they lapse. The company said it will intimate the stock exchange upon conversion or on lapse of the instrument tenure, aligning the process with exchange disclosure requirements.

Other board actions: management re-appointments

Alongside the warrant issue, the board meeting on August 25, 2026 also approved the re-appointment of the Chairman and Managing Director and two Whole Time Directors. The re-appointments are for three-year terms, as stated in the update.

These decisions indicate that the board meeting covered both capital-raising proposals and key leadership continuity items. The company has positioned the leadership decisions as formal re-appointments rather than new appointments, suggesting continuity in the executive structure.

Expansion of business objects through MoA changes

The board also approved alterations to the Memorandum of Association on August 25, 2026. The stated purpose was to expand permitted business activities into heavy machinery, infrastructure development, and general investments. As per the disclosure, the proposal requires final approval from shareholders.

This MoA change is a separate governance and strategy-related step from the preferential issue, but it can be relevant for investors tracking the company’s stated scope of operations. Since shareholder approval is required, the company’s next steps will likely include placing the proposal before shareholders at the scheduled meeting.

Trading window closure around the announcement

Shree Hari Chemicals Export announced a closure of its trading window from August 19, 2026 until 48 hours after the board meeting scheduled for August 25, 2026. The trading window was set to reopen on August 27, 2026. The company cited compliance with SEBI regulations and its internal code of conduct for insider trading.

The board meeting agenda, as described in the disclosures, included considering and approving the issuance of warrants on a preferential basis and the convening of the 39th Annual General Meeting. The trading window closure is a standard compliance step around price-sensitive developments.

Prior preferential issue: ‘nil deviation’ utilisation statement

The company filed a statement confirming nil deviation or variation in the utilisation of proceeds from its preferential issue for the quarter ended June 30, 2026. It stated that the funds raised amounting to ₹14.75 crore were fully utilised as per the original objects disclosed. The filing was made pursuant to Regulation 32(1) under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure also referenced that the company raised ₹14.75 crore through preferential issues on multiple dates in 2024 and 2025 and reported no deviations for the quarter ended March 31, 2026 as well. This background is relevant because it provides context on how earlier preferential proceeds were tracked and reported.

Market snapshot and what investors typically track next

As of August 23, 2026, Shree Hari Chemicals Export’s share price was ₹152.2, as stated in the provided text. The warrants are priced at ₹176.10, and the company’s disclosures provide a defined conversion window of 18 months from allotment. Investors typically track whether shareholder approval is received, when allotment occurs, and the pace of subsequent conversions.

Because the allottees are promoters, market participants also tend to monitor resulting promoter shareholding after conversion, which the company has summarised as a 5.36% to 8.13% post-conversion range for the promoters involved. Another key operational disclosure to watch is the company’s exchange intimations when conversions occur or if any warrants lapse.

Key facts table

Conclusion

Shree Hari Chemicals Export’s board has approved a ₹40.24 crore preferential warrant issue to promoter entities, with conversion permitted in tranches within 18 months of allotment and a 25%-75% payment schedule. The proposal is subject to shareholder approval, and the company has also put forward MoA changes and re-appointments of key managerial personnel for shareholder consideration where required. The next confirmed procedural milestones are shareholder approvals and subsequent exchange intimations as and when warrant conversions occur or if any instruments lapse.